The Pyxis Tankers Inc EPS (TTM) is -0.05. Pyxis Tankers Inc reported sales of The Pyxis Tankers Inc EPS (TTM) is -0.05. Pyxis Tankers Inc reported sales of 9.15, net income of -2.00, and EPS of -0.19 ...

Pyxis Finvest Limited was originally incorporated with the Registrar of Companies, on November 25, 2005 as BCB Finance Private Limited. The Company, through the Shareholders Resolution was converted ...

Explore the NASDAQ:PYXS financials. Find the Pyxis Oncology financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key ...

Pyxis Oncology is developing next-generation therapeutics, including antibody-drug conjugates and immuno-oncology programs, to target solid tumors resistant to current treatments. PYXS's lead product ...

Pyxis Oncology is developing antibodies and antibody-drug conjugates for various tumor types. Initial data from the phase 1 trials of PYX-106 and PYX-201 are now expected in H2'24 and fall 2024 ...

Pyxis Oncology announces Phase 1/2 trials for PYX-201, combining it with KEYTRUDA® to treat advanced solid tumors. Pyxis Oncology, Inc. has announced the initiation of two significant clinical trials ...